Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Effectiveness of Ampicillin-Sulbactam and Ceftriaxone for Treating Community-Acquired Pneumonia in Elderly Patients: Insights from a Target Trial Emulation Analysis

  • By

  • Shungo Yamamoto

  • Akihiro Shiroshita

  • Yuki Kataoka

  • Hidehiro Someko

  • March 5, 2025

Share

Objective:

To compare the effectiveness of ampicillin-sulbactam with ceftriaxone as initial treatment for community-acquired pneumonia (CAP) in older adults.

Key Findings:
  • Include adjusted odds ratios for a more comprehensive understanding.
Interpretation:

Strengthen the emphasis on the implications of higher mortality.

Limitations:
  • Mention potential confounding factors as a limitation.
Conclusion:

Suggest areas for further research.

Original Source(s)

Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study

  • by Shungo Yamamoto, Akihiro Shiroshita, Yuki Kataoka, Hidehiro Someko

  • March 5, 2025

Related Content

Review Highlights Infectious Diarrhea

The authors emphasize the importance of shared decision-making and reassessing goals of care.

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Medical Oddities: When Men Face Catcalling

Cooking, catcalling, and colon swaps—medicine keeps things interesting.